LDN-071

N/A

Report date: 2024/01/09 11:54:56
NMEFirst In Class

Base Information

Drug NameLDN-071
Drug Alias NameLDN-071
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionPlasminogen activator inhibitor 1 inhibitors
TargetsPlasminogen activator inhibitor 1
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHungary
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLadon Therapeutics Kft
China Registration ClassN/A

Develop Information

Active CompaniesLadon Therapeutics Kft
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A